We measured Wnt signaling in breast cancer cells after stable overexpression or knockdown of TMEM170B, which is a direct target of miR-27a, to investigate the regulation of TMEM170B on the Wnt/β-catenin pathway. This evidence concerns the gene TMEM170B and breast carcinoma.